Literature DB >> 25130683

Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia.

Yixin Hu, Xin Lv, Yujie Wu, Ji Xu, Lingling Wang, Weifeng Chen, Wei Zhang, Jianyong Li, Sujiang Zhang, Hongxia Qiu.   

Abstract

OBJECTIVES: This study focused on the expression pattern and clinical significance of B7-H3 expression in human acute leukemia.
METHODS: We systematically analyzed 134 patients with acute myeloid leukemia (101 cases) and acute lymphocytic leukemia (33 cases) by flow cytometry.
RESULTS: The frequency of B7-H3(+) cases was 44.8% in total. The B7-H3 expression rate differed from 0% to 74.8% in individual cases. The correlation between B7-H3 expression and traditional prognostic factors, such as age and gender, the white blood cell count was not confirmed. However, B7-H3 had a significant higher expression in CD34(+) cases and high risk karyotypes.
CONCLUSIONS: Owing to the expression of B7-H3 being statistically relevant in predicting disease progression and a shorter life survival, our results demonstrated that B7-H3 expression in acute leukemia predicts an unfavorable outcome.

Entities:  

Keywords:  Acute lymphocytic leukemia; Acute myeloid leukemia; B7-H3; Costimulatory molecule; Prognosis

Mesh:

Substances:

Year:  2014        PMID: 25130683     DOI: 10.1179/1607845414Y.0000000186

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  20 in total

1.  Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging.

Authors:  Sunitha V Bachawal; Kristin C Jensen; Katheryne E Wilson; Lu Tian; Amelie M Lutz; Jürgen K Willmann
Journal:  Cancer Res       Date:  2015-04-21       Impact factor: 12.701

2.  B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway.

Authors:  Bo Jiang; Fen Liu; ZhiHui Liu; Ting Zhang; Dong Hua
Journal:  Tumour Biol       Date:  2016-01-20

3.  Prognostic values of increased B7 family proteins in haploidentical hematopoietic stem cell transplantation patients with aGVHD.

Authors:  Biqi Zhou; Tanzhen Wang; Lei Lei; Yutong Lu; Li Zhang; Xiaowen Tang; Huiying Qiu; Aining Sun; Xueguang Zhang; Yang Xu; Depei Wu
Journal:  Int J Hematol       Date:  2019-02-06       Impact factor: 2.490

4.  Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.

Authors:  Elodie Picarda; Kim C Ohaegbulam; Xingxing Zang
Journal:  Clin Cancer Res       Date:  2016-05-20       Impact factor: 12.531

5.  PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance.

Authors:  Alessandra Dondero; Fabio Pastorino; Mariella Della Chiesa; Maria Valeria Corrias; Fabio Morandi; Vito Pistoia; Daniel Olive; Francesca Bellora; Franco Locatelli; Aurora Castellano; Lorenzo Moretta; Alessandro Moretta; Cristina Bottino; Roberta Castriconi
Journal:  Oncoimmunology       Date:  2015-07-15       Impact factor: 8.110

6.  Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.

Authors:  Ling Wang; Na-Na Cao; Shan Wang; Hong-Wei Man; Peng-Fei Li; Bao-En Shan
Journal:  Tumour Biol       Date:  2015-09-28

7.  Overexpression of B7-H3 as an opportunity for targeted therapy in head and neck cancers.

Authors:  Juanjuan Hu; Caiying Jiang; Meijun Zheng; Yuxin Guo; Xin Tang; Jia Ren; Dan Lu; Lingyu Yu; Weigang Gan; Shixi Liu; Aiping Tong; Hui Yang
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

8.  A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3-Specific CAR T Cells in Solid Tumors.

Authors:  Xinyuan Lei; Zhanpeng Ou; Zhaohui Yang; Jianglong Zhong; Yanliang Zhu; Jing Tian; Jiannan Wu; Heran Deng; Xinyu Lin; Yu Peng; Bowen Li; Lile He; Zhiming Tu; Weixiong Chen; Qunxing Li; Niu Liu; Hanqing Zhang; Zhangsong Wang; Zezhen Fang; Teppei Yamada; Xiaobin Lv; Tian Tian; Guokai Pan; Fan Wu; Liping Xiao; Lizao Zhang; Tingting Cai; Xinhui Wang; Bakhos A Tannous; Jinsong Li; Filippos Kontos; Soldano Ferrone; Song Fan
Journal:  Clin Cancer Res       Date:  2021-04-02       Impact factor: 12.531

9.  B7-H3 targeted antibody-based immunotherapy of malignant diseases.

Authors:  Theodoros Michelakos; Filippos Kontos; Omar Barakat; Luke Maggs; Joseph H Schwab; Cristina R Ferrone; Soldano Ferrone
Journal:  Expert Opin Biol Ther       Date:  2020-12-21       Impact factor: 4.388

10.  Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration.

Authors:  Hongxia Li; Emily B Harrison; Huizhong Li; Koichi Hirabayashi; Jing Chen; Qi-Xiang Li; Jared Gunn; Jared Weiss; Barbara Savoldo; Joel S Parker; Chad V Pecot; Gianpietro Dotti; Hongwei Du
Journal:  Nat Commun       Date:  2022-04-20       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.